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Abstract 1731 is a Drosophila melanogaster retrotransposon 
whose nucleotide sequence shows a proviral architecture with two 
long terminal repeats (LTRs) framing two internal Open Reading 
Frames (ORFs). The pol ORF2 of this mobile genetic element 
was demonstrated to code for an active Reverse Transcriptase 
(RT) and the ORFI is expected to code for the structural Gag 
proteins of the virus-fike particles (VLP). Using specific anti-Gag 
antibodies, we have characterized the 1731 Gag polypeptides 
expressed either in vitro or in Kc Drosophila melanogaster cul- 
tured cells. Together with the 1731 RT, the largest, likely post- 
translationaly-modified Gag polypeptides are gathered into cyto- 
plasmic virus-like particles. Moreover and consistent with the 
nuclear localization signal present in the Gag sequence, we ob- 
served that a short 1731 Gag polypeptide is associated to the cell 
nuclei. 
Key words: 1731 retrotransposon; Virus-like particle; 
Gag protein; Nucleus 
1. Introduction 
LTR-retrotransposons are the representatives of a wide class 
of mobile genetic elements first isolated in Drosophila melan- 
ogaster and subsequently found in all eukaryotic genomes ex- 
amined so far. Analyses of their nucleotide sequences has 
shown the striking resemblance of their structural organisation 
with that of the integrated form of Vertebrate retroviruses 
[1~,]. All these transposable elements are usually composed of 
an internal sequence with two or three ORFs, and of two 
flanking sequences, the LTRs (Long Terminal direct Repeats). 
Internal sequences homologous to retroviral gag and pol genes 
have been reported in all retrotransposons described so far. 
Such a canonical structure has been reported for the Drosophila 
melanogaster 1731 retrotransposon: the internal sequence 
should be the template for both the structural protein compo- 
nents of the virus-like particle (Gag proteins) and the enzymes 
involved in the replication of the genomic RNA, namely the 
protease, the integrase and the RNase H-reverse transcriptase 
(RT) (Pol proteins) [5]. In retrotransposons, such an internal 
order of the pol genes is a typical feature of the copia/Ty 1group 
[2-4,6]. 
It was reported that 1731 transcripts are abundantly repre- 
sented in Kc Drosophila melanogaster cultured cells [7]. We 
decided to search for the existence of 1731 translation products, 
expecting that analysis of the production of 1731-encoded 
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structural and/or catalytic peptides would reveal some of the 
mechanisms involved in the expression control of the element, 
either at the translational or post-translational level. Thus, we 
have described the presence of an authentic RT activity en- 
coded by the 1731 element, detected into the cytoplasmic VLPs- 
containing fractions prepared from Kc cells [8], suggesting that 
the element could be able to transpose. However, pol-derived 
enzymes are not the only proteins involved in transposition: 
structural Gag proteins were reported to play an active r61e in 
the replication/ transposition cycle of retroelements. In the 
yeast-Saccharomyces revisiae, the importance of both Gag 
and Gag-Pol polyproteins on transposon replication/transposi- 
tion was established through the demonstration that synthesis 
of Gag protein is a necessary and essential step to support he 
Tyl transposition events [9-11]. Besides, the complex mecha- 
nism of the Gag processing could be one of the targets for a 
control strategy. Some preliminary indications in favour of 
such control have been already reported in the case of the Ty 
element [10]. Following our previous investigation on 1731 RT, 
we searched for the presence of the 1731 gag product in Kc 
cells, not only to examine whether this protein was assembled 
into VLPs, but also to probe its localization into different 
cellular compartments. 
We presently report he existence of 1731 Gag proteins in the 
cellular fractions that contain the VLPs extracted from a Droso- 
phila melanogaster cell line. Moreover, we observed that a 1731 
Gag polypeptide is associated with the nucleus, a cell localiza- 
tion consistent with the presence of a putative nuclear localiza- 
tion signal (NLS)[12] in its sequence; a feature suggesting that, 
as indicated for some retroviral Gag polypeptides [13,14], 1731- 
encoded Gag protein could have some essential nuclear func- 
tion. 
2. Materials and methods 
2.1. Cell lines 
The Drosophila melanogaster Kc0 [15] and D. hydei DH33 cell lines 
[16] were used for the preparation ofprotein extracts [17]. Following 
electrophoresis, proteins were electroblotted onto nitrocellulose (Schle- 
icher and Schuell) or Immobilon (Millipore) membrane by standard 
methods. Western blots were probed with preabsorbed anti-Gag anti- 
serum (~ 1 : 1,000) and HRP-conjugated secondary antibodies 
(1:4,000) (Dako); then positive bands were revealed by using 
the DAB-CoC12 method or a highly sensitive chemiluminescent system 
(Boehringer). 
2.2. Preparation of ant&era gainst 1731 Gag recombinant protein 
A Gag recombinant protein was produced in IPTG-induced RB791 
Escherichia coli strain transtbrmed with pRBA50, which is the 
pTrc99A[18] derivative obtained by in frame insertion of the 568 bp 
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BamHI-Pstl fragment corresponding to the central region of the 1731 
gag gene, and able to produce a23kDa polypeptide (see Fig. 1). Plasmid 
pRBB8 made by an out of frame insertion of the same gag sequence 
into pTrc99B [18] was used as a negative control. Four anti-Gag anti- 
sera (GPI, lI, III, IV) were obtained from guinea-pigs immunized 
against the Gag recombinant protein according standard protocols [19]. 
2.3. In vitro translation of 1731 RNAs 
pAHAR1 is the pKS(+) Bluescript Vector (Stratagene) in which the 
pFP5c ApaI EeoR1 fragment (see Fig. 1) was inserted. After digestion 
by restriction enzymes, i.e. NruI, SphI or EcoRV, 1731 RNAs were 
produced in vitro (transcription system-Stratagene) a d further trans- 
lated in a rabbit reticulocyte lysate (Promega or Stratagene) in the 
presence of[35S]methionine (30 MBq/ml)(Amersham) for 1 h at 37°C. 
Total synthesized 35S-labelled proteins and immunoprecipitated p p- 
tides obtained with anti-Gag and anti-RT antibodies by using the pro- 
tein A-Sepharose method [20] were analysed on fluorographed poly- 
acrylamide gels. Fluorographs were scanned using a Hoefer GS300 
densitometer (Hoefer Scientific Ins.) 
2.4. Nuclei preparation 
Drosophila cell nuclei were isolated at 4°C as previously described 
[21]: about 5 x 109 cells suspended in PBS were pelleted (800 x g, 5 min, 
4°C) and resuspended in 10 mM HEPES (pH 7.6), 1.5 mM MgC12, 10 
mM KC1 and 0.5 mM dithiothreitol. After being allowed to stand 10 
min at 4°C, cells were pelleted and resuspended in 2 volumes of the 
same buffer. They were disrupted by 20 strokes in a Dounce homoge- 
nizer (B-type pestle) and centrifuged (Beckman JA21 rotor, 2,500 rpm, 
10 rain ). The supernatant was decanted and the nuclear pellet was 
centrifuged again through a 20% sucrose cushion (Beckman JA21 
rotor-14,500 x g, 20 min). The nuclear pellet was then solubilized in 
sample buffer [17]. Samples were loaded onto SDS-polyacrylamide gels 
and electroblotted. Ponceau red staining of proteins electrotransferred 
onto nitrocellulose membrane monitored the presence of histones as 
major nuclear proteins. 
2.5. VLP preparation, RT assay and immunoblotting 
Drosophila cultured cells (about 3 x 109 cells ) were gently detached 
from Falcon flasks, washed in TEN buffer (10 mM Tris, pH 8, 1 mM 
Naz EDTA, 150 mM NaC1) and homogenized in the same buffer con- 
taining 10/~g/ml ofprotease inhibitors (antipain, leupeptin, pepstatin 
and aprotinin). Following centrifugation (15,000 x g, 15 min), the post- 
mitochondrial supernatant [20] was layered onto a 20-30-70% sucrose 
step gradient in TEN buffer, spun 16 hours in a 50.2 Ti Beckman rotor 
(35,000 rpm, 4°C). In each gradient fraction the reverse transcriptase 
activity was tested, using Poly(rCm)-p(dG)(Pharmacia) as template 
primer [22], and proteins analyzed by immunoblotting under previously 
described conditions [8,12]. In some other assays the post-mitochon- 
drial supernatant was directly spun over a 20% sucrose cushion 
(150,000 x g, 1 h) in order to obtain a rapid preparation of pelleted 
particulated forms. 
3. Results 
3.1. Characterization of anti-Gag antibodies 
In order to test the specificity of anti-Gag antibodies raised 
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Fig. 1. Restriction map and genetic architecture of 1731. Schematic 
representation of the genomic 1731 element inplasmid pFP5C [5] show- 
ing the two ORFs and putative nzymatic domains of the ORF2: 
PR,protease; INT, integrase; RH, RNAseH; RT, reverse transcriptase. 
Thin line: flanking genomic sequences. Restriction sites used in this 
work are indicated. Hatched boxes represent parts of the genes ex- 
pressed as recombinant proteins used for the preparation of antisera. 
in guinea-pigs, Western blots of extracts from transformed 
E. coli cells were probed. Only a peptide of Mr ~ 23,000 produced 
in IPTG-induced RBA50 bacteria was recognized by the GPI 
antiserum (1:1,000 dilution) preabsorbed two times on the 
acetonic powder prepared from IPTG-induced RB791/RBB8 
bacteria. Specificity of anti-Gag antibodies was confirmed by 
the fact that no protein was detected in IPTG-induced bacteria 
harbouring either pRBB8 or pCM294 plasmid (unpublished 
data). The later construct bears a 1731-ORF2 sequence and 
directs the expression of a 70 kDa protein, unrelated to the Gag 
peptide(KS construct in [8]). As described below, specificity of 
anti-Gag antibodies was also provided by the analysis of in 
vitro translation products. 
3.2. Characterization of in vitro-produced Gag proteins 
Fig. 2 shows the analysis of labelled polypeptides synthetized 
after translating 1731 RNAs produced from template DNAs 
containing either only a gag fragment or various gag-pol frag- 
ments. As expected, the ApaI-NruI RNA was translated as a 
27-28 kDa peptide (lane 1), corresponding to a truncated Gag 
peptide. However, the Apal Sphl RNA generated a peptide of 
about 32 kDa; this size is consistent with that of the entire 
ORF1 product, but lower than that expected for a 1.3 kb long 
coding sequence which was presumed to give a Gag-Protease 
fusion peptide (lane 2). Only in kinetic experiments and during 
the first 15-30 rain of the translation reaction, was this expected 
45 kDa polypeptide detected as a minor, weakly-labelled poly- 
peptide representing about 5-6% of [35S]methionine incorpo- 
rated into the 32 kDa Gag peptide (not shown). When using 
the nearly entire translatable sequence of the 1731 element, 
contained in the ApaI-EcoRV RNA, larger peptides (Mrs from 
50,000 to 110,000) and the 32,000 peptide were generated (lane 
3). Taking account of the number of methionines present into 
the 1731 peptides, two in the Gag sequence and twenty-five in 
the Pol sequence, and measurements of incorporated 
[35S]methionine, wecalculated that 8 to 10 times more Gag pep- 
tide than Pol peptide were synthetized. Such a Gag/Pol ratio 
is usually found with other retrotransposable el ments harbor- 
ing a frameshift event during the translation of the gag-pol 
sequence (see section 4). 
Immunoprecipitation experiments performed with anti-Gag 
(GPI serum) and a previously described immunopurified anti- 
sera raised against he 1731 RT [8] allowed us to characterize 
both Gag and RT (pro)peptides. Two main translational prod- 
ucts were immunoprecipited by the anti-RT antibodies (lane 7, 
arrowheads): a species displaying an M~ ~ 105/110,000 was ex- 
pected to derive from the entire Pol peptide and the other 
polypeptide of Mr ~90,000 could derive from processing of the 
Pol polyprotein. GPI anti-Gag antibodies immunoprecipated 
only the radiolabelled polypeptides displaying the lower MW 
(Mr 32,000) translated from the tested 1731 RNAs, but no 
pol-derived peptides was recognized (lane 6). Noteworthy, these 
sizes fitted well to that expected for 1731 gag products (~30,000 
kDa). These data ensured that GP sera recognize proteins en- 
coded by the 1731 gag gene (see section 4). Therafter, GP 
antisera were used to probe Western blots of proteins extracted 
from D. melanogaster cultured cells and flies. 
3.3. 1731 Gag protein is associated to VLPs 
We previously had shown the colocalization of RT activity 
and 1731 RT-related polypeptides in VLPs-containing fractions 
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derived from a Kc cells post-mitochondrial supernatant [8]. In 
the present study, using the GPI antiserum, we analyzed a 
similar subcellular f action extracted either from D.melanogas- 
ter Kc cells or from D. hydei DH33 cells. In Kc cells, anti-Gag 
antibodies detected a major band displaying an apparent size 
of ~42 kDa and, as expected from the absence of any 1731- 
related sequence in D. hydei genomic DNA, no immunoreactive 
material was revealed in DH33 cells (Fig. 3A), indicating that 
1731 Gag protein is present only in D. melanogaster species. 
Moreover, after fractionation of the Kc cells post-mitochon- 
drial supernatant over a sucrose gradient, we reproducibly de- 
tected a single immunoreactive protein band of Mr ~40,000 Da, 
found only in fractions displaying the strongest RT activity and 
as indicated by density measurement, coincident with the 
VLPs-containing fractions found at a density level of about 1,2 
mg/ml [23] (Fig. 3B). These data demonstrate he association 
into the same fraction of both 1731-RT and 1731-Gag and 
suggest hat these proteins are incorporated into the same 
structures. 
As orderly species of Gag proteins have been described in 
both retroviruses and retrotransposons [24,25], the appearance 
of a single immunoreactive 1731 Gag protein in the gradient 
fractions was surprising. In order to search other forms of 1731 
Gag, we concentrated cytoplasmic particles by pelleting a post- 
mitochondrial supernatant through a sucrose cushion, at 
150,000 x g for one hour. The proteinaceous pellet was solubil- 
ized and proteins eparated on a 10-20% polyacrylamide na- 
turing gel before being transferred onto nitrocellulose. Im- 
munoblot analysis using a sensitive chemiluminescent detection 
reaction revealed several GPI immunoreactive peptides, the 
most strongly labelled harboring Mr o f -44 ,  ~40, ~27 and 
10 kDa (Fig. 4, lane C); the two larger forms likely correspond 
to the 42-40 kDa species observed in Fig. 3 and the fast mi- 
grating forms could be protease-processed forms of the Gag 
protein. The significance of these forms will be discussed. 
3.4. A 1731 Gag-related protein is associated to the nuclear 
fraction 
In a previous tudy, we have transfected D. virilis cultured 
cells with a plasmid bearing the E. coli lacZ gene fused to the 
1731 gag gene. Some cells showed a 1731 Gag-fl-galactosidase 
fusion protein associated with the nucleus [12], suggesting that 
the gag product could be directed to the nucleus. Next, nuclei 
from Drosophila melanogaster Kc0 cultured cells were purified 
and nuclear extract was prepared and immunoblotted (see sec- 
tion 2). The GPI antiserum revealed one major protein band 
of M r ~22,000 Da and minor faint bands of M r ~40,000 and 
-30,000 Da (Fig. 4, lane N). The latter are similar in size 
to one major (40 kDa) and one minor (30 kDa) band of the 
150,000 × g pellet obtained from a postmitochondrial superna- 
tant(lane C). In contrast, the band displaying an Mr of 22,000 
kDa was recorded only in the nuclear extract when no corre- 
sponding immunoreactive protein was detected at this level in 
the cytoplasmic extract. This suggested that this 1731 Gag- 
related 22 kDa protein might be a nuclear-associated specific 
form. 
4. Discussion 
Analysis of the amino-acid sequence of 1731 ORF 1 revealed 
the presence of a nucleic acid binding domain and led us to 
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Fig. 2. In vitro translated 1731 proteins. In vitro-produced 1731 RNAs 
obtained from fragments of the 1731 ApaI EcoRI template inserted in 
pAHRI recombinant were translated in 20 pl of rabbit reticulocyte 
lysate (Stratagene or Promega) in the presence of [35S]methionine. 10 
/A of labelled translation products were analysed on a 15% poly- 
acrylamide denaturing gel, either directly or following immunoprecipi- 
tation. The Coomassie blue-stained gel was prepared for fluorography 
using Na salicylate, dried and exposed on X-ray film. Lanes 1-3: trans- 
lation products ynthetized with RNAs obtained from the 1731 tem- 
plates, ApaI-NruI (1), ApaI-SphI (2), ApaI EcoRV (3). Lanes 4-5: 
controls, no RNA (4) and BMV(Brome Mosaic Virus) RNA (5). Lanes 
6--7: immunoprecipitated translation products from the ApaI EcoRV 
RNA, either with the GPI antiserum (6) or with the purified anti-RT 
antibodies (7) fixed on ProteinA-Sepharose b ads. The four BMV 
translated products (*) (20, 35, 97 and 110 kDa, lane5) from BMV RNA 
(Promega) and reference proteins (Combitek-Boehringer) were used as 
size markers. Arrows on the left indicate the presence of endogenous 
synthetized peptides. Arrowheads: major immunoprecipitated peptides 
(lane 7). 
consider it as a putative retroviral-like Gag protein [5] which 
is expected to be the main structural component of 1731 VLPs. 
Following insertion of the E. coli lacZ gene into the NruI site 
of 1731 (see fig. 1), we had obtained the first evidence for the 
existence of 1731 Gag-like proteins; indeed, 1731 Gag-fl-galac- 
tosidase fusion proteins were found into VLPs-containing, RT- 
active fractions extracted from Drosophila virilis transfected 
cells [12]. As Gag proteins from both retrotransposons and 
retroviruses have been repeatedly proven to be difficult o char- 
acterize when only the Mr was considered [24,25], we prepared 
antibodies directed against he central part of the 1731 Gag 
protein, assuming that they would allow recognition of gag 
products in cells and/or in organisms. 
4.1. Antibody specificity 
The specificity of antibodies was demonstrated through sev- 
eral analyses: (i) in E. coli, the p23 recombinant Gag polypep- 
tide is the only peptide recognized by the preabsorbed antisera; 
(ii) immunoprecipitation experiments showed that the Gag and 
Pol products were clearly and unambiguously distinguished by 
antibodies directed against each peptide (Fig. 2, compare lanes 
6-7); (iii) as expected, comparison of VLPs-containing fractions 
extracted from both Drosophila rnelanogaster and D. hydei cul- 
tured ceils demonstrated that 1731 Gag is detectable only in 
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Fig. 3. 1731 Gag protein in the cytoplasmic fraction of D. melanogaster cultured cells (A) absence of 1731 Gag in D. hydei cells. Post-mitochondrial 
cytoplasmic extracts of D. melanogaster and D. hydei cells were centrifuged over a sucrose gradient; proteins from 150,000 ×g pellets and supernatants 
were separated on a 12,5% polyacrylamide g l and immunoblotted with anti-Gag antiserum. Lanes 12:Kc0 D. melanogaster cells; 3-4: D. hydei 
cells; 1-3:150,000 × g supernatants; 2-4:150,000 x g pellets. Size markers are indicated on the left side of the figure. (B) presence of 1731 Gag in 
VLP-containingfractions (A) Upper part: RT activity in gradient fractions. Abscissa: fraction umber. Ordinate: cpm of incorporated [32P]dGMP. 
(B) Lower part: Western blot of the corresponding fractions. Arrow indicate the 1731Gag protein positioned at ~42 kDa. Cytoplasmic extract from 
Kc0 cells was fractionated on a sucrose step gradient (see section 2). From each 0.8 ml fraction, 20~tl were tested for their RT activity and 50/tl were 
analysed by immunoblotting of the proteins eparated on a 12,5% polyacrylamide g l. The blot was probed with the GPI preabsorbed serum (1 : 1000 
estimated concentration); the second antibody was used at a 1:4000 dilution and HRP activity revealed using the Boehringer chemiluminescence 
Western blotting reagents. Size markers were from Boehringer (Combitek) and from Novex USA(Mark 12). 
Drosophila melanogaster cells (Fig. 3A). All these assays 
showed that these antisera can recognize their target proteins 
even if those are produced in various systems, i.e. in vitro 
systems or cells. Moreover, the colocalization of both 1731 
RT-specific and 1731 Gag immunoreactivities along the step 
gradient fractionation is further circumstantial evidence for the 
specificity of the antisera raised against he recombinant 1731 
Gag protein. Strengthening for this evidence came from the 
observation that immunoreactive fractions also displayed the 
strongest VLPs-associated RT activity (Fig. 3B). 
4.2. Comparison of  in vitro and in vivo products 
4.2.1. Translationalframeshift. Study of various retroele- 
ments had shown that the ORF 1-derived Gag proteins are both 
the main translational products and components of viral or 
viral-like particles, whereas the amount of Gag-Pol products 
resulting from a translational frameshift represents only few 
percent of the former [26,27]. From 1731 sequence analysis it 
was expected that 1731 Gag-Pol precursor should be produced 
by a + 1 frameshift and consequently would be a transient and 
minor form of translated products. Indeed, in the in vitro as- 
says, the final level ofpol-derived peptides was about 8-10% of 
that found for the gag products. This result is in agreement with 
those obtained either for other etrotransposons, especially Tys 
in the yeast (reviewed by Farabaugh [28]), or in experiments 
using 1731 pol-CAT constructs which produced a CAT activity 
ten times lower than the activity generated by the 1731 5'LTR- 
CAT construct (C. Coulondre and Best-Belpomme, unpub- 
lished results). Surprisingly, in early in vitro translation exper- 
iments, no protein species fitting with the expected 1731 Gag- 
Pol fusion protein were detected (see Fig. 2, lanes 2, 3, 7). As 
an example, in addition to the p32 Gag peptide, the ApaI-SphI 
RNA was expected to generate a 45 kDa peptide containing the 
putative protease (Fig. 2, lane 2). Exclusively, in kinetic exper- 
iments, a weakly labelled peptide displaying such a size was 
recorded transiently during the first 15-30 rain of the transla- 
tion experiment . We hypothesise that this peptide corre- 
sponded to a 1731 Gag-Protease-containing peptide and was 
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Fig. 4. Cytoplasmic and nuclear-associated species of 1731 Gag Pro- 
teins of the post-mitochondrial cytoplasmic and nuclear fractions pre- 
pared from Kc0 cultured cells (see section 2) were analysed on a 10-20% 
polyacrylamide gradient gel, and immunoblotted onthe same nitrocel- 
lulose membrane. Immuno detection was made with GPI absorbed 
anti-Gag antiserum and HRP-conjugated secondary antibodies re- 
vealed by using a chemiluminescence system (Boehringer). Lane C: 
1731 Gag in pelleted (150,000 x g - 1 h - 4°C) proteins extracted from 
a Kc0 cytoplasmic fraction. Lane N: 1731 Gag in Kc0 nuclear fraction. 
Size markers: 'Rainbow' colored markers (Amersham). Arrowheads 
indicate the major peptides described in the text. 
detectable only during a short period preceeding the proteolytic 
processing which allows the separation of the Gag and Pol 
moieties. This rapid processing could be attributed to either an 
instability of the truncated peptide or an in vitro enhanced 
protease activity and might explain why we were unable to 
detect he large Gag-Pol fusion peptides in our in vitro experi- 
ments. Interestingly, in some tissues of the fly, we have recently 
characterized a 1731 Gag-Pol polyprotein of around 140-145 
kDa, recognized by both anti-Gag and anti-RT antibodies 
(in preparation). All these data suggest hat in one hand a 
frameshift usually occurs in about 8-10% of translated 1731 
RNAs and on the other hand, in most Drosophila tissues, the 
Gag-Pol polyprotein is rapidly processed by the protease. 
4.2.2. The in vivo synthetized gag protein is larger than the in 
vitro translated products. 1731 ORF1 was expected to produce 
a polypeptide displaying a size in the 30 kDa range. By in vitro 
translation of 1731 RNAs (Fig. 2 lanes 1-3), a Gag polypeptide 
showing an Mr of 32 kDa was formed, consistent with the 
predicted size and immunologically identified by anti-Gag anti- 
bodies. This product, which is not post-translationally modi- 
fied, is presumed to be the precursor peptide really synthetized 
in vivo. 
In contrast, in Kc cell extract, the 1731 Gag protein was 
found in VLP-containing fractions, as a single species of about 
40-42 kDa (Fig. 3). Its apparent molecular weight is quite 
similar to that found in fly extracts (unpublished result), but 
higher than the predicted 32 kDa or the Gag polypeptide syn- 
thetized in vitro (Fig. 2). The p32 species is thought o be the 
primary, unmodified form of the Gag protein and the p40-42 
should correspond to a post-translationally modified p32. Such 
apparent larger sizes of Gag proteins are frequently encoun- 
tered and were reported for the two yeast retrotransposons Tyl
and Ty3 [25, 28-30]. However, the nature of the post-transla- 
tional modification of 1731 Gag is unknown. For retroviral 
Gag proteins, addition of hydrophobic side chains as myristic 
or palmitic acid on some particular amino-acid positions is 
known to induce abnormal migration during electrophoresis. 
As for RSV Gag protein [31], it can be speculated that the 
presence of a glycine residue in the penultimate place of the 
amino-terminal side of the 1731 Gag protein could be involved 
in acylation modification; such hypotheses will be tested by 
using a mutated 1731 gag gene. It is noteworthy that such 
modifications are believed to play a r61e in localizing the retro- 
viral Gag proteins to the plasma membrane during virus assem- 
bly [31]; conversely one can suppose that non-myristoylated 
Gag proteins are immobilized in the cytoplasm. 
Analysis of the VLPs-containing fractions was fullfilled by 
testing a rather crude preparation (Fig.4, lane C): four major 
bands were recognized by anti-Gag antibodies. The MW of the 
two largest polypeptides (40~,5 kDa) are similar to those al- 
ready observed in VLP-containing fractions and could corre- 
spond to the Gag polypeptide doublet described for other etro- 
elements [29,30]. The significance of the peptides displaying 
lower MWs (27, 10 kDa) is hypothetical: in absence of any 
possibility to distinguish immunologically the amino or car- 
boxy-end of the Gag protein, it can be proposed that they are 
cleavage products of the p4~45, similar to capsid and nucleo- 
capsid peptides described for other retrotransposons [28]. 
4.3. Nuclear-localization f a Gag species 
Conceptual translation of 1731 gag sequence revealed a 
polypeptidic sequence, SAKKRKDV which is similar to the 
Nuclear Localization Signal (NLS) present in proteins con- 
veyed through the nuclear membrane from cytoplasm to nucle- 
oplasm [33]. Consistently, we observed that some 1731 Gag-fl- 
galactosidase fusion protein was associated to the nucleus of 
Drosophila virilis transfected cells [12]. Therefore, following the 
analysis of Kc cells cytoplasmic fractions, we tested a nuclear 
extract for the presence of 1731 Gag polypeptides. An unex- 
pected prominent product in the Mr 22,000 range was immunol- 
ogically revealed: no corresponding band was found neither in 
the postmitochondrial pellet nor in VLP extract, i.e. in cyto- 
plasmic extracts (Fig. 3, 4N). As both extracts have been treated 
in the same way and separated on the same gel, it is clear that 
the p22 nuclear-associated species belongs exclusively to this 
fraction and that other Gag species are essentially of cytoplas- 
mic origin. This nuclear localization could be attributable to the 
presence of a karyophilic signal which might be unmasked and 
functional or accessible only in this p22 form of 1731 Gag. 
Indeed, we described previously a putative karyophilic signal 
or NLS in the C-terminal end of the 1731 Gag amino sequence( 
nucleotide position: 1075-1099 in [5]). We hypothesised that 
such a sequence was brought by the p22 peptide, enabling its 
nuclear localization. This polypeptide is expected to derive 
from the C-terminal moiety of the 1731 Gag protein and to 
possess not only the NLS but also a nucleic acid binding site 
(nucleotide position: 1099-1147 in [5]). It is now well estab- 
lished that proteolytic ontrol is involved in the mechanism of 
72 A. Haoudi et al./FEBS Letters 377 (1995) 6~72 
nuclear addressing of some transcription factors [34]. Similarly, 
a specific proteolysis of the Gag precursor would be required 
to generate the p22 nuclear-associated species. 
Among other retroviral elements, a NLS-containing Gag 
protein was reported for HIV-1 [13]; it was suggested that this 
NLS is able to induce an accumulation of non-myristoylated 
Gag products into the nuclei of infected cells and of Spodoptera 
insect cells transfected by a HIV-1 mutated gag gene [35]. Nu- 
clear localization was also reported for eopia Gag proteins 
overexpressed in yeast cells [36]. We can now propose that this 
direction to the nucleus could be monitored by a NLS-like 
sequence (nucleotide position: 1079 to 1102 in the cDm2055 
plasmid - see [36]); this sequence is found close to the nucleic 
acid binding site (nucleotide position 1123 to 1165 ), suggesting 
similar structural organisations in the Gag products of both 
copia and 1731. It has also been reported that the Gag product 
of Moloney Leukemia Virus was associated with the nucleopro- 
tein complex involved in the process of transposition [37]. In 
addition the localization of Gag protein of foamy viruses was 
found to be nuclear, a localization due to the presence of 
glycine-arginine rich boxes (NLS-like) in its sequence [14]. 
Altogether, these observations strongly suggest hat during 
the life cycle of the retrotransposon, 1731 Gag products might 
have a more complex role than building up the VLP's wall, 
likely by directing some retrotranscription products to the nu- 
cleus. Compared to the behaviour of retroviral Gag peptides 
which are usually driven to the plasma membrane, the purely 
intracellular localization of the retrotransposon's VLPs could 
actually be due to some mutation located on the Gag product 
which impedes the budding process, and in turn allows an 
enhancement of targeting to the nucleus. In such a context, the 
putative functional role of the 1731 p22 Gag protein in the 
retrotransposon lifecycle, either through a targeting of reverse 
transcripts to the nucleus or through an unknown regulatory 
function only operative in the nucleus, has now to be investi- 
gated. 
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